Go back

Go to
Robin Filmer-Wilson

“As a dedicated health impact investor, all our funds carry the Article 8 or 9 designation, signifying our commitment to guide healthcare actors in forging resilient, equitable and sustainable healthcare systems. We take immense pride in our role as industry catalyst, driving investments that promise a healthier, more sustainable future for all: humans, animals, and the environment”.



Sector: Pharma Services


Robin Filmer-Wilson is a Partner at ARCHIMED, and a Director of the EURÊKA Foundation, ARCHIMED’s charitable foundation. He currently co-heads the Pharma Services sector team. Robin has a long-standing relationship with the other ARCHIMED partners.

Robin has over 25 years of healthcare private equity experience in the US, Asia, the UK and Europe. Having been born and raised in Hong-Kong, Robin was educated in Europe and the US. He holds a BSFS from Georgetown University and an MBA from INSEAD.

Robin led the transactions of a UK-based occupational health provider, Vita Health, and France-based nutraceutical company specializing in polyphenols, Fytexia. He currently sits on the Boards of UK-based pharma strategic consulting firm, Deallus, a Netherlands-based manufacturer of single-use and reusable tapes for operating rooms, SMG, a US-based manufacturer of wearables for clinical trials, ActiGraph, a France-based CRO and Bioanalytical service company, Aliri and a Canada-based CDMO and formulation development firm, Corealis.


Soest Medical Group (SMG)
Vita Health Group (ex Rehabworks)